219 related articles for article (PubMed ID: 34601004)
1. Disruption of pulmonary resolution mediators contribute to exacerbated silver nanoparticle-induced acute inflammation in a metabolic syndrome mouse model.
Alqahtani S; Xia L; Jannasch A; Ferreira C; Franco J; Shannahan JH
Toxicol Appl Pharmacol; 2021 Nov; 431():115730. PubMed ID: 34601004
[TBL] [Abstract][Full Text] [Related]
2. Enhanced silver nanoparticle-induced pulmonary inflammation in a metabolic syndrome mouse model and resolvin D1 treatment.
Alqahtani S; Xia L; Shannahan JH
Part Fibre Toxicol; 2022 Aug; 19(1):54. PubMed ID: 35933425
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of Nanoparticle-Induced Acute Pulmonary Inflammation in a Mouse Model of Metabolic Syndrome.
Alqahtani S; Kobos LM; Xia L; Ferreira C; Franco J; Du X; Shannahan JH
Front Immunol; 2020; 11():818. PubMed ID: 32457752
[TBL] [Abstract][Full Text] [Related]
4. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
5. Specialized Pro-Resolving Lipid Mediators Regulate Ozone-Induced Pulmonary and Systemic Inflammation.
Kilburg-Basnyat B; Reece SW; Crouch MJ; Luo B; Boone AD; Yaeger M; Hodge M; Psaltis C; Hannan JL; Manke J; Armstrong ML; Reisdorph N; Tighe RM; Shaikh SR; Gowdy KM
Toxicol Sci; 2018 Jun; 163(2):466-477. PubMed ID: 29471542
[TBL] [Abstract][Full Text] [Related]
6. Frontline Science: A reduction in DHA-derived mediators in male obesity contributes toward defects in select B cell subsets and circulating antibody.
Crouch MJ; Kosaraju R; Guesdon W; Armstrong M; Reisdorph N; Jain R; Fenton J; Shaikh SR
J Leukoc Biol; 2019 Aug; 106(2):241-257. PubMed ID: 30576001
[TBL] [Abstract][Full Text] [Related]
7. The omega-3 fatty acid docosahexaenoic acid attenuates organic dust-induced airway inflammation.
Nordgren TM; Friemel TD; Heires AJ; Poole JA; Wyatt TA; Romberger DJ
Nutrients; 2014 Nov; 6(12):5434-52. PubMed ID: 25436433
[TBL] [Abstract][Full Text] [Related]
8. Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models.
Kobos L; Alqahtani S; Xia L; Coltellino V; Kishman R; McIlrath D; Perez-Torres C; Shannahan J
J Toxicol Environ Health A; 2020 Apr; 83(7):249-268. PubMed ID: 32281499
[TBL] [Abstract][Full Text] [Related]
9. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
10. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.
Rodriguez-Echevarria R; Macias-Barragan J; Parra-Vargas M; Davila-Rodriguez JR; Amezcua-Galvez E; Armendariz-Borunda J
World J Gastroenterol; 2018 Jan; 24(4):461-474. PubMed ID: 29398867
[TBL] [Abstract][Full Text] [Related]
11. Novel Mechanisms of Ozone-Induced Pulmonary Inflammation and Resolution, and the Potential Protective Role of Scavenger Receptor BI.
Gowdy KM; Kilburg-Basnyat B; Hodge MX; Reece SW; Yermalitsk V; Davies SS; Manke J; Armstrong ML; Reisdorph N; Tighe RM; Shaikh SR
Res Rep Health Eff Inst; 2021 Mar; 2021(204):1-49. PubMed ID: 33998222
[TBL] [Abstract][Full Text] [Related]
12. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
13. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
14. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
Neuhofer A; Zeyda M; Mascher D; Itariu BK; Murano I; Leitner L; Hochbrugger EE; Fraisl P; Cinti S; Serhan CN; Stulnig TM
Diabetes; 2013 Jun; 62(6):1945-56. PubMed ID: 23349501
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.
Hsiao HM; Sapinoro RE; Thatcher TH; Croasdell A; Levy EP; Fulton RA; Olsen KC; Pollock SJ; Serhan CN; Phipps RP; Sime PJ
PLoS One; 2013; 8(3):e58258. PubMed ID: 23484005
[TBL] [Abstract][Full Text] [Related]
16. Lipid mediators of inhalation exposure-induced pulmonary toxicity and inflammation.
Pitchai A; Buhman K; Shannahan JH
Inhal Toxicol; 2024 Feb; 36(2):57-74. PubMed ID: 38422051
[TBL] [Abstract][Full Text] [Related]
17. A High Docosahexaenoic Acid Diet Alters the Lung Inflammatory Response to Acute Dust Exposure.
Dominguez EC; Heires AJ; Pavlik J; Larsen TD; Guardado S; Sisson JH; Baack ML; Romberger DJ; Nordgren TM
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32759853
[TBL] [Abstract][Full Text] [Related]
18. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423
[TBL] [Abstract][Full Text] [Related]
19. Synbiotic Compositions of
Speckmann B; Kleinbölting J; Börner F; Jordan PM; Werz O; Pelzer S; Tom Dieck H; Wagner T; Schön C
Nutrients; 2022 May; 14(11):. PubMed ID: 35684065
[TBL] [Abstract][Full Text] [Related]
20. Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies.
Beck-Speier I; Karg E; Behrendt H; Stoeger T; Alessandrini F
Part Fibre Toxicol; 2012 Jul; 9():27. PubMed ID: 22809365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
